ClinicalTrials.gg
CompletedNCT07047794Updated Jan 26, 2026

Scapula Position and Range of Motion, Strength and Performance in Thoracic Hyperkyphosis

An observational study in Hyperkyphosis, sponsored by Istinye University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 7 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by Istinye University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
36
Ages
7 Years to 14 Years
Sex
All
01

Study summary

In the sagittal plane, the average kyphosis angle between the superior endplate of the T1 vertebra and the inferior endplate of the T12 vertebra is approximately 40 degrees. A thoracic spine angle greater than 45 degrees is defined as hyperkyphosis. The most common types of hyperkyphosis observed in juveniles and adolescents are Scheuermann's kyphosis, postural hyperkyphosis, and congenital hyperkyphosis.

Postural hyperkyphosis is the most prevalent form among these types. It results from the weakness of the muscles responsible for maintaining an upright posture and occurs due to external forces acting on the spine. The curvature of the spine in this condition is not rigid and can generally be corrected when the individual is asked to stand upright. Postural hyperkyphosis is typically seen during adolescence.

An increased thoracic kyphosis angle in postural hyperkyphosis can affect scapular kinematics, potentially leading to shoulder pathologies later in life, such as impingement syndrome, rotator cuff tendinopathy, rotator cuff tears, glenohumeral instability, and adhesive capsulitis. Additionally, hyperkyphosis can negatively affect body image and overall quality of life. If it begins in childhood and remains untreated, hyperkyphosis may persist into adulthood and contribute to increased healthcare expenditures. Given the growing prevalence of technology dependence and its association with rising hyperkyphosis incidence, early management of this deformity during juvenile and adolescent periods is essential in terms of both health and economic outcomes. In managing postural hyperkyphosis, it is important to address not only the angular correction of the deformity but also to consider the entire spine within the kinetic chain model.

The kinetic chain model is a biomechanical concept that defines the body as a system of interconnected segments. Any dysfunction within one segment of the kinetic chain can affect the quality of movement in both the upper and lower segments. The scapula serves as a foundation within this model, acting as a force transmitter that converts potential energy generated by muscles into kinetic energy in the upper extremity. Hyperkyphosis can lead to scapular protraction and downward rotation, disrupting the normal positioning of the scapula. As a result, joint range of motion, strength, and performance in the upper extremity may be negatively affected.

Studies in the literature have shown that scapular positioning and movements play a critical role in upper extremity function. However, no study has been found that specifically investigates the impact of altered scapular position on upper extremity performance in children with thoracic hyperkyphosis. Considering the increasing prevalence of thoracic hyperkyphosis in children due to rising technology addiction, and the potential for this deformity to contribute to upper extremity pathologies in adulthood, identifying its effects is crucial for improving children's physical performance and reducing future healthcare costs.

02

Conditions studied

  • Hyperkyphosis

Browse trials for

Keywords

  • thoracic hyperkyphosis
  • scapula
  • kinetic chain
  • upper extremity performance
03

In context

Kyphosis

132 studies on the registry are indexed under Kyphosis; 31 are open to participants now.

This study's enrollment of 36 is below the median of 62 across 45 observational studies indexed under Kyphosis.

Browse Kyphosis studies →

Lead sponsor

Istinye University is the lead sponsor of 221 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 14 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Children with thoracic hyperkyphosis will be included in our study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 7-14 years old
  • Thoracic kyphosis angle (Cobb) on lateral radiograph: ≥45˚ or kyphosis index ≤13

Exclusion criteria

Exclusion Criteria:

  • Those who have had major surgery or trauma related to the musculoskeletal system, especially the spine and upper extremities
  • Difficulty in perceiving commands
  • Rigid deformity in the spine (Scheuermann kyphosis)
  • Congenital deformity
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
36 participants (actual)
Patient registry
No

Groups and cohorts

  • Group 1

    Other: Assessment

Interventions

  • OtherAssessment

    Children with thoracic hyperkyphosis between the ages of 7 and 14 who meet the inclusion criteria will be included in this study, which was conducted to examine the scapular position and its relationships with upper extremity joint range of motion, strength and performance in children with thoracic hyperkyphosis.

06

What researchers measure

Primary outcomes

  1. Sociodemographic Status

    The sociodemographic status of the participants will be recorded with an evaluation form prepared by the researchers. Information on age, gender, dominant side, exercise habits will be questioned. Participants' privacy will be respected throughout the study, and no photographs will be taken.

    Time frame: 4 weeks

  2. Upper Extremity Range of Motion

    Bilateral shoulder flexion, extension, abduction, elbow flexion, extension and wrist flexion and extension range of motion will be measured with a digital goniometer whose validity and reliability have been demonstrated.

    Time frame: 4 weeks

  3. Upper Extremity Muscle Strength

    Bilateral trapezius upper-middle-lower fibers, serratus anterior, shoulder flexion, extension, abduction, elbow flexion, extension and wrist flexion and extension muscle strength will be measured with a myometer whose validity and reliability have been demonstrated.

    Time frame: 4 weeks

  4. Flexicurve Ruler

    Flexicurve Ruler is a method that is preferred more than other methods because it is cheap, easy to use and has high validity and reliability. In our study, kyphosis curvatures will be measured with Flexicurve Ruler and kyphosis index will be calculated. Kyphosis index is the value found by dividing the width of the thoracic curvature by its length.

    Time frame: 4 weeks

  5. Wall-Occiput Distance

    The increase in the thoracic kyphosis angle will be evaluated and recorded with the wall-occiput distance measurement. The distance between the occiput and the wall will be measured with a ruler while the individual to be tested stands in contact with the wall

    Time frame: 4 weeks

  6. Scapula Position

    The Lateral Scapular Shift Test will be used to determine the scapula position in the 0, 45 and 90° abduction positions of the shoulder joint. Measurements of the scapular position will be made bilaterally in three test positions, between the spinous processes of the thoracic vertebrae in line with the inferior angle of the scapula.

    Time frame: 4 weeks

  7. Closed Kinetic Chain Upper Extremity Stability Test

    Upper extremity will be used for strength, endurance and closed kinetic chain assessment. The test will be applied in a push-up position with the distance between the two hands set at 90 cm, then the number of repetitions completed within 15 seconds by extending one hand towards the other hand will be recorded.

    Time frame: 4 weeks

  8. Upper Extremity Y-Balance Test

    It will be used to evaluate the balance, functionality and stability of the upper extremity and trunk. The evaluation will begin in a push-up position with both arms shoulder-width apart. Starting with the non-dominant hand, the maximum reachable distance in the medial, inferolateral and superolateral directions will be recorded

    Time frame: 4 weeks

  9. Medicine Ball Throwing Test

    Upper extremity will be used to evaluate explosive power. In this test, the distance covered by throwing a 3 kg ball will be recorded

    Time frame: 4 weeks

  10. Height

    The vertical distance from the top of the head to the heels of the individual. It will be measured in centimeters.

    Time frame: 4 weeks

  11. Weight

    The mass of the individual's body in relation to gravity. It will be expressed in kilograms.

    Time frame: 4 weeks

  12. Waist Circumference

    A circumferential measurement taken with a tape measure at the narrowest point of the waist, or at the midpoint between the lower margin of the last palpable rib and the top of the iliac crest, to assess abdominal fat distribution. It will be measured in centimeters

    Time frame: 4 weeks

07

Study locations

1 site
  • Istinye University
    Istanbul, 34010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2025 to primary completion in Dec 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2025
First posted
Jul 2, 2025
StartActual
Jun 23, 2025
Primary completionActual
Dec 1, 2025
CompletionActual
Dec 30, 2025
Last update
Jan 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07047794
Lead sponsor
Istinye University
Responsible party
Kubra Koce (Asst. Prof., Istinye University) — Principal investigator
First posted
Jul 2, 2025
Start date
Jun 23, 2025
Primary completion
Dec 1, 2025
Completion
Dec 30, 2025
Last update
Jan 26, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion